Monday to Saturday - 8:00 -17:30
PHARMA GIANT’S VALUE SURGES, OUTPACING OPENAI

In an astonishing development, pharmaceutical behemoth Novo Nordisk has witnessed its market worth skyrocket to approximately $506 billion, primarily fueled by the exceptional performance of its semaglutide-based injectable medications, Ozempic and Wegovy. This surge in valuation has eclipsed the estimated…